BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25015158)

  • 1. Optimizing prostate specimen handling for diagnosis and prognosis.
    Bostwick DG; Day CE; Meiers I
    Methods Mol Biol; 2014; 1180():337-52. PubMed ID: 25015158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens].
    CompƩrat E; Camparo P; Srigley J; Delahunt B; Egevad L;
    Ann Pathol; 2013 Jun; 33(3):155-61. PubMed ID: 23790653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.
    Epstein JI
    J Urol; 2011 Sep; 186(3):790-7. PubMed ID: 21788055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).
    Egevad L; Judge M; Delahunt B; Humphrey PA; Kristiansen G; Oxley J; Rasiah K; Takahashi H; Trpkov K; Varma M; Wheeler TM; Zhou M; Srigley JR; Kench JG
    Pathology; 2019 Jan; 51(1):11-20. PubMed ID: 30477882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of biopsies in staging of prostatic cancer before radical prostatectomy].
    Salomon L; Hoznek A; Lefrere-Belda MA; Bellot J; Chopin D; Abbou CC
    Prog Urol; 1998 Dec; 8(6):969-76. PubMed ID: 9894255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International society of urological pathology consensus conference on handling and staging of radical prostatectomy specimens.
    Egevad L; Srigley JR; Delahunt B
    Adv Anat Pathol; 2011 Jul; 18(4):301-5. PubMed ID: 21654361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.
    D'Amico AV; Wu Y; Chen MH; Nash M; Renshaw AA; Richie JP
    J Urol; 2001 Jan; 165(1):126-9. PubMed ID: 11125380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraprostatic extension of prostatic adenocarcinoma on needle core biopsy: report of 72 cases with clinical follow-up.
    Miller JS; Chen Y; Ye H; Robinson BD; Brimo F; Epstein JI
    BJU Int; 2010 Aug; 106(3):330-3. PubMed ID: 20002671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features of prostate cancers detected after an initial diagnosis of 'atypical glands suspicious for cancer'.
    Zhou M; Magi-Galluzzi C
    Pathology; 2010 Jun; 42(4):334-8. PubMed ID: 20438405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.
    Epstein JI; Amin M; Boccon-Gibod L; Egevad L; Humphrey PA; Mikuz G; Newling D; Nilsson S; Sakr W; Srigley JR; Wheeler TM; Montironi R
    Scand J Urol Nephrol Suppl; 2005 May; (216):34-63. PubMed ID: 16019758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of benign prostatic glandular tissue at surgical margins does not predict PSA recurrence.
    Kernek KM; Koch MO; Daggy JK; Juliar BE; Cheng L
    J Clin Pathol; 2005 Jul; 58(7):725-8. PubMed ID: 15976340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?
    de la Taille A; Rubin MA; Bagiella E; Olsson CA; Buttyan R; Burchardt T; Knight C; O'Toole KM; Katz AE
    J Urol; 1999 Jul; 162(1):103-6. PubMed ID: 10379750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of perineural invasion and other biopsy characteristics as prognostic markers for localized prostate cancer.
    Epstein JI
    Semin Urol Oncol; 1998 Aug; 16(3):124-8. PubMed ID: 9741416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Murphy GP; Busch C; Abrahamsson PA; Epstein JI; McNeal JE; Miller GJ; Mostofi FK; Nagle RB; Nordling S; Parkinson C
    Scand J Urol Nephrol Suppl; 1994; 162():7-42; discussion 115-27. PubMed ID: 7817162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor volume in radical prostatectomy specimens assessed by digital image analysis software correlates with other prognostic factors.
    Sherwin JC; Mirmilstein G; Pedersen J; Lawrentschuk N; Bolton D; Mills J
    J Urol; 2010 May; 183(5):1808-14. PubMed ID: 20303103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perineural invasion on prostate biopsy does not predict adverse pathological outcome.
    Elharram M; Margel D; Finelli A; Trachtenberg J; Evans A; van der Kwast TH; Sweet JM; Fleshner N
    Can J Urol; 2012 Dec; 19(6):6567-72. PubMed ID: 23228294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy.
    DeLancey JO; Wood DP; He C; Montgomery JS; Weizer AZ; Miller DC; Jacobs BL; Montie JE; Hollenbeck BK; Skolarus TA
    Urology; 2013 Feb; 81(2):354-7. PubMed ID: 23374801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?
    Makarov DV; Sanderson H; Partin AW; Epstein JI
    J Urol; 2002 Jun; 167(6):2440-2. PubMed ID: 11992053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic role of perineural invasion in prostate biopsy].
    GutiƩrrez C; Terrasa F; Briones G; Conde G; Fuentes I; Hidalgo F; Bestard J; Rebassa M
    Actas Urol Esp; 2011 Jun; 35(6):347-53. PubMed ID: 21435742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
    Gao X; Mohideen N; Flanigan RC; Waters WB; Wojcik EM; Leman CR
    J Urol; 2000 Dec; 164(6):1982-6. PubMed ID: 11061896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.